NO940837L - Fettsyreavsluttede polyanhydrider - Google Patents

Fettsyreavsluttede polyanhydrider

Info

Publication number
NO940837L
NO940837L NO940837A NO940837A NO940837L NO 940837 L NO940837 L NO 940837L NO 940837 A NO940837 A NO 940837A NO 940837 A NO940837 A NO 940837A NO 940837 L NO940837 L NO 940837L
Authority
NO
Norway
Prior art keywords
fatty acid
terminated polyanhydrides
polyanhydrides
terminated
fatty
Prior art date
Application number
NO940837A
Other languages
English (en)
Norwegian (no)
Other versions
NO940837D0 (no
Inventor
Abraham J Domb
Manoj Maniar
Original Assignee
Scios Nova Inc
Nova Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Nova Inc, Nova Pharm Corp filed Critical Scios Nova Inc
Publication of NO940837D0 publication Critical patent/NO940837D0/no
Publication of NO940837L publication Critical patent/NO940837L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G67/00—Macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing oxygen or oxygen and carbon, not provided for in groups C08G2/00 - C08G65/00
    • C08G67/04—Polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polyethers (AREA)
NO940837A 1991-09-09 1994-03-09 Fettsyreavsluttede polyanhydrider NO940837L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/756,483 US5179189A (en) 1990-01-19 1991-09-09 Fatty acid terminated polyanhydrides
PCT/US1992/007601 WO1993005096A1 (en) 1991-09-09 1992-09-08 Fatty acid terminated polyanhydrides

Publications (2)

Publication Number Publication Date
NO940837D0 NO940837D0 (no) 1994-03-09
NO940837L true NO940837L (no) 1994-05-02

Family

ID=25043688

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940837A NO940837L (no) 1991-09-09 1994-03-09 Fettsyreavsluttede polyanhydrider

Country Status (8)

Country Link
US (1) US5179189A (ja)
EP (1) EP0605536A4 (ja)
JP (1) JP3294273B2 (ja)
AU (1) AU667325B2 (ja)
CA (1) CA2118584C (ja)
FI (1) FI941087A (ja)
NO (1) NO940837L (ja)
WO (1) WO1993005096A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317079A (en) * 1990-01-19 1994-05-31 Nova Pharmaceutical Corporation Fatty acid terminated polyanhydride
AU660511B2 (en) * 1991-11-26 1995-06-29 Kansai Paint Company, Limited Cross-linking agent and curable composition
AU5018693A (en) * 1992-09-21 1994-04-12 Upjohn Company, The Sustained-release protein formulations
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
DE69511418T2 (de) 1995-10-28 2000-03-30 Braun Melsungen Ag Lokalanästhetika und/oder Zentralanalgetika enthaltende pharmazeutische Zusammensetzungen
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
EP1545705A4 (en) 2000-11-16 2010-04-28 Microspherix Llc FLEXIBLE AND / OR ELASTIC BRACHYTHERAPY SEED OR STRAND
IL140017A (en) * 2000-11-30 2009-09-22 Abraham J Domb Polyhedra
US7749539B2 (en) * 2000-11-30 2010-07-06 Efrat Biopolymers Ltd. Polymeric formulations for drug delivery
US8143368B2 (en) * 2004-12-23 2012-03-27 Massachusetts Institute Of Technology Disposable medical supplies from hydrolytically biodegradable plastics
JP5410020B2 (ja) * 2005-02-02 2014-02-05 ノヴォ ノルディスク アー／エス インスリン誘導体
EP2049149B1 (en) 2006-07-31 2015-04-15 Novo Nordisk A/S Pegylated extended insulins
JP5864834B2 (ja) * 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス プロテアーゼ耐性のインスリンアナログ
EP2152358B1 (en) 2007-04-27 2011-03-02 Echo Therapeutics, Inc. Skin permeation device for analyte sensing or transdermal drug delivery
US9387176B2 (en) * 2007-04-30 2016-07-12 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
US20100190706A1 (en) * 2007-06-01 2010-07-29 Novo Nordisk A/S Stable Non-Aqueous Pharmaceutical Compositions
JP5762001B2 (ja) * 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化インスリンアナログ
PT2254906T (pt) 2008-03-18 2017-01-03 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
AU2014333979B2 (en) 2013-10-07 2018-02-15 Novo Nordisk A/S Novel derivative of an insulin analogue
CA2970617C (en) 2014-12-18 2021-11-23 Dexcel Pharma Technologies Ltd. Alternating and semi-alternating poly(ester-anhydride) copolymers
CN110087674B (zh) 2016-12-16 2023-01-03 诺和诺德股份有限公司 含胰岛素的药物组合物
CA3057766A1 (en) 2017-03-29 2018-10-04 Dexcel Pharma Technologies Ltd. Compositions comprising biodegradable copolymers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA684685A (en) * 1964-04-21 C. Pugh Edgar Polymers
US4526957A (en) * 1983-02-24 1985-07-02 Calgon Corporation Copolymers of maleic anhydride and alkylene oxide to inhibit the precipitation and deposit of scale in aqueous systems
US4888176A (en) * 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4757128A (en) * 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4501877A (en) * 1983-12-05 1985-02-26 Eastman Kodak Company Higher molecular weight polyesters from diacid anhydrides and cyclic alkylene carbonates
US4891225A (en) * 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4886870A (en) * 1984-05-21 1989-12-12 Massachusetts Institute Of Technology Bioerodible articles useful as implants and prostheses having predictable degradation rates
CH671402A5 (ja) * 1985-10-02 1989-08-31 Sandoz Ag
US4789724A (en) * 1986-10-17 1988-12-06 Massachusetts Institute Of Technology Preparation of anhydride copolymers
US4933431A (en) * 1987-07-31 1990-06-12 Massachusetts Institute Of Technology One step preparation of poly(amide-anhydride)
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US4857311A (en) * 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
US4868274A (en) * 1988-05-23 1989-09-19 Hoechst Celanese Corp. Polyanhydride from carboxy aryloxy alkanoic acid
US4868265A (en) * 1988-10-05 1989-09-19 Hoechst Celanese Corp. Polyanhydride process from bis(trimethylsilyl) ester of dicarboxylic acid

Also Published As

Publication number Publication date
JP3294273B2 (ja) 2002-06-24
EP0605536A1 (en) 1994-07-13
FI941087A0 (fi) 1994-03-08
AU2644492A (en) 1993-04-05
FI941087A (fi) 1994-04-28
US5179189A (en) 1993-01-12
WO1993005096A1 (en) 1993-03-18
JPH07503030A (ja) 1995-03-30
CA2118584A1 (en) 1993-03-18
NO940837D0 (no) 1994-03-09
AU667325B2 (en) 1996-03-21
EP0605536A4 (en) 1994-07-20
CA2118584C (en) 2004-03-23

Similar Documents

Publication Publication Date Title
NO940837L (no) Fettsyreavsluttede polyanhydrider
DE69117037D1 (de) Förderer
DE69229860D1 (de) Reklamemontage
DK0584142T3 (da) Fjerkræhåndteringsenhed
DE69218027D1 (de) Bezugsgenerator
DK0510614T3 (da) Generator
NO920420D0 (no) 3-quinuklidin-derivater
BR9202341A (pt) Fecho de correr
FI942259A (fi) Lämmönsiirrin
FI101214B1 (fi) Rullaushylsyjen kiinnityspää
DE69124084D1 (de) Oberflächenlegierung
FI922348A (fi) Persondator med alternativ systemstyrenhet
FI934935A (fi) Maetcell foer elektrokinetisk potential
DE69224760T2 (de) Ethyl-6-formyloxy-4-hexenoat
KR930006731U (ko) 스팡글 띠
KR930002161U (ko) 의지용 슬리이브 카바
KR940003910U (ko) 보일러
KR920019109U (ko) 증류기
KR930001103U (ko) 점화기
NO924608D0 (no) Bunting
KR920021758U (ko) 광고등
BR9200091A (pt) Marmita termoeletrica
BR9200589A (pt) Chingrural energia eolica
KR930001102U (ko) 점화장치
NO914551D0 (no) Generator